As used in NRS 683A.171 to 683A.179, inclusive, unless the context otherwise requires, the words and terms defined in NRS 683A.172 to 683A.176, inclusive, have the meanings ascribed to them in those sections. (Added to NRS by 2017, 4307)
“Covered person” means a person who is covered by a pharmacy benefits plan. (Added to NRS by 2017, 4307)
“Pharmacy” has the meaning ascribed to it in NRS 639.012. (Added to NRS by 2017, 4307)
“Pharmacy benefit manager” means an entity that contracts with or is employed by a third party and manages the pharmacy benefits plan provided by the third party. (Added to NRS by 2017, 4307)
“Pharmacy benefits plan” means coverage of prescription drugs provided by a third party. (Added to NRS by 2017, 4307)
“Third party” means: 1. An insurer, as that term is defined in NRS 679B.540; 2. A health benefit plan, as that term is defined in NRS 687B.470, for employees which provides a pharmacy benefits plan; 3. A participating public agency, as that term is defined in NRS 287.04052, and any other local governmental agency of […]
1. Except as otherwise provided in subsection 2, the requirements of NRS 683A.171 to 683A.179, inclusive, and any regulations adopted by the Commissioner pursuant thereto do not apply to the coverage of prescription drugs under a plan that is subject to the Employee Retirement Income Security Act of 1974 or any information relating to such […]
1. A pharmacy benefit manager has an obligation of good faith and fair dealing toward a third party or pharmacy when performing duties pursuant to a contract to which the pharmacy benefit manager is a party. Any provision of a contract that waives or limits that obligation is against public policy, void and unenforceable. 2. […]
1. A pharmacy benefit manager shall not: (a) Prohibit a pharmacist or pharmacy from providing information to a covered person concerning: (1) The amount of any copayment or coinsurance for a prescription drug; or (2) The availability of a less expensive alternative or generic drug including, without limitation, information concerning clinical efficacy of such a […]
